NM_001278116.2:c.2211G>A

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_001278116.2(L1CAM):​c.2211G>A​(p.Pro737Pro) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000962 in 1,205,873 control chromosomes in the GnomAD database, including 4 homozygotes. There are 542 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. P737P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00056 ( 0 hom., 17 hem., cov: 22)
Exomes 𝑓: 0.0010 ( 4 hom. 525 hem. )

Consequence

L1CAM
NM_001278116.2 splice_region, synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -3.87

Publications

1 publications found
Variant links:
Genes affected
L1CAM (HGNC:6470): (L1 cell adhesion molecule) The protein encoded by this gene is an axonal glycoprotein belonging to the immunoglobulin supergene family. The ectodomain, consisting of several immunoglobulin-like domains and fibronectin-like repeats (type III), is linked via a single transmembrane sequence to a conserved cytoplasmic domain. This cell adhesion molecule plays an important role in nervous system development, including neuronal migration and differentiation. Mutations in the gene cause X-linked neurological syndromes known as CRASH (corpus callosum hypoplasia, retardation, aphasia, spastic paraplegia and hydrocephalus). Alternative splicing of this gene results in multiple transcript variants, some of which include an alternate exon that is considered to be specific to neurons. [provided by RefSeq, May 2013]
L1CAM Gene-Disease associations (from GenCC):
  • L1 syndrome
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • X-linked hydrocephalus with stenosis of the aqueduct of Sylvius
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, G2P
  • MASA syndrome
    Inheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
  • X-linked complicated corpus callosum dysgenesis
    Inheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • X-linked complicated spastic paraplegia type 1
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.032).
BP6
Variant X-153866869-C-T is Benign according to our data. Variant chrX-153866869-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 211338.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.87 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.000564 (63/111775) while in subpopulation SAS AF = 0.00856 (23/2686). AF 95% confidence interval is 0.00585. There are 0 homozygotes in GnomAd4. There are 17 alleles in the male GnomAd4 subpopulation. Median coverage is 22. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 17 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
L1CAMNM_001278116.2 linkc.2211G>A p.Pro737Pro splice_region_variant, synonymous_variant Exon 19 of 29 ENST00000370060.7 NP_001265045.1 P32004-1
L1CAMNM_000425.5 linkc.2211G>A p.Pro737Pro splice_region_variant, synonymous_variant Exon 18 of 28 NP_000416.1 P32004-1
L1CAMNM_024003.3 linkc.2211G>A p.Pro737Pro splice_region_variant, synonymous_variant Exon 18 of 27 NP_076493.1 P32004-2
L1CAMNM_001143963.2 linkc.2196G>A p.Pro732Pro splice_region_variant, synonymous_variant Exon 17 of 26 NP_001137435.1 P32004-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
L1CAMENST00000370060.7 linkc.2211G>A p.Pro737Pro splice_region_variant, synonymous_variant Exon 19 of 29 5 NM_001278116.2 ENSP00000359077.1 P32004-1

Frequencies

GnomAD3 genomes
AF:
0.000573
AC:
64
AN:
111722
Hom.:
0
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.0000979
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000284
Gnomad ASJ
AF:
0.00151
Gnomad EAS
AF:
0.000281
Gnomad SAS
AF:
0.00891
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000490
Gnomad OTH
AF:
0.00201
GnomAD2 exomes
AF:
0.00171
AC:
306
AN:
179429
AF XY:
0.00256
show subpopulations
Gnomad AFR exome
AF:
0.000156
Gnomad AMR exome
AF:
0.000330
Gnomad ASJ exome
AF:
0.00135
Gnomad EAS exome
AF:
0.0000727
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000997
Gnomad OTH exome
AF:
0.00157
GnomAD4 exome
AF:
0.00100
AC:
1097
AN:
1094098
Hom.:
4
Cov.:
31
AF XY:
0.00146
AC XY:
525
AN XY:
359766
show subpopulations
African (AFR)
AF:
0.000152
AC:
4
AN:
26347
American (AMR)
AF:
0.000370
AC:
13
AN:
35143
Ashkenazi Jewish (ASJ)
AF:
0.00129
AC:
25
AN:
19354
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30176
South Asian (SAS)
AF:
0.0106
AC:
571
AN:
54031
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40027
Middle Eastern (MID)
AF:
0.0107
AC:
41
AN:
3826
European-Non Finnish (NFE)
AF:
0.000435
AC:
365
AN:
839267
Other (OTH)
AF:
0.00170
AC:
78
AN:
45927
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
34
67
101
134
168
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000564
AC:
63
AN:
111775
Hom.:
0
Cov.:
22
AF XY:
0.000501
AC XY:
17
AN XY:
33965
show subpopulations
African (AFR)
AF:
0.0000977
AC:
3
AN:
30716
American (AMR)
AF:
0.000283
AC:
3
AN:
10590
Ashkenazi Jewish (ASJ)
AF:
0.00151
AC:
4
AN:
2645
East Asian (EAS)
AF:
0.000281
AC:
1
AN:
3553
South Asian (SAS)
AF:
0.00856
AC:
23
AN:
2686
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6109
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
219
European-Non Finnish (NFE)
AF:
0.000490
AC:
26
AN:
53062
Other (OTH)
AF:
0.00198
AC:
3
AN:
1512
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00130
Hom.:
8
Bravo
AF:
0.000499

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Mar 01, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 04, 2015
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Sep 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Spastic paraplegia Benign:1
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
May 28, 2017
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Hereditary spastic paraplegia Benign:1
Dec 12, 2016
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.72
CADD
Benign
0.27
DANN
Benign
0.81
PhyloP100
-3.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs146782397; hg19: chrX-153132324; API